NPR | Alzheimer's Prevention Registry

You are here

NPR

Hope, Happiness And Social Connection: Hidden Benefits Of Regular Exercise

If ever there was a time to up your fitness game, the arrival of the new year and the new decade is it. But after the allure of the new gym membership wears off, our sedentary habits, more often than not, consume our promise of daily workouts. It doesn't have to be this way, says health psychologist and author, Kelly McGonigal.

Keeping Your Blood Sugar In Check Could Lower Your Alzheimer's Risk

Brain scientists are offering a new reason to control blood sugar levels: It might help lower your risk of developing Alzheimer's disease.

How Deep Sleep May Help The Brain Clear Alzheimer's Toxins

The brain waves generated during deep sleep appear to trigger a cleaning system in the brain that protects it against Alzheimer's and other neurodegenerative diseases.

New Markers For Alzheimer's Disease Could Aid Diagnosis And Speed Up Drug Development

Alzheimer's disease begins altering the brain long before it affects memory and thinking.

So scientists are developing a range of tests to detect these changes in the brain, which include an increase in toxic proteins, inflammation and damage to the connections between brain cells.

Researchers Explore Why Women's Alzheimer's Risk Is Higher Than Men's

Scientists are beginning to understand why Alzheimer's disease affects more women than men and why the disease seems to progress more quickly in women's brains.

A Genetic Test That Reveals Alzheimer's Risk Can Be Cathartic Or Distressing

In a waiting room at the Banner Alzheimer's Institute in Phoenix, a 74-year-old woman named Rubie is about to find out whether she has a gene that puts her at risk for Alzheimer's.

Is Aerobic Exercise The Right Prescription For Staving Off Alzheimer's?

Researchers are prescribing exercise as if it were a drug in a study that aims to see if it can prevent Alzheimer's disease.

After A Big Failure, Scientists And Patients Hunt For A New Type Of Alzheimer's Drug

Scientists are setting a new course in their quest to treat Alzheimer's disease. The shift comes out of necessity. A series of expensive failures with experimental drugs aimed at a toxic protein called amyloid-beta have led to a change in approach. The most recent disappointment came in March, when drugmaker Biogen and its partner Eisai announced they were halting two large clinical trials of an amyloid drug called aducanumab.

Alzheimer's Disease May Develop Differently In African-Americans, Study Suggests

Scientists have found a biological clue that could help explain why African-Americans appear to be more vulnerable than white Americans to Alzheimer's disease.

Pfizer Halts Research Into Alzheimer's And Parkinson's Treatments

Pfizer has announced plans to end its research efforts to discover new drugs for Alzheimer's and Parkinson's diseases.